C136H103Cl2F18N33O10 — CID 157049630
N-(2-bicyclo[2.2.2]oct-5-enylmethyl)-4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]benzamide;2-(2,4-dichlorophenyl)-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]acetamide;3-phenylmethoxy-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;2-phenyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]acetamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]oxane-4-carboxamide (PubChem CID 157049630) has the molecular formula C136H103Cl2F18N33O10 and a molecular weight of 2772.41 g/mol. Its IUPAC name is N-(2-bicyclo[2.2.2]oct-5-enylmethyl)-4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]benzamide;2-(2,4-dichlorophenyl)-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]acetamide;3-phenylmethoxy-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;2-phenyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]acetamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]oxane-4-carboxamide.
| Compound Name | N-(2-bicyclo[2.2.2]oct-5-enylmethyl)-4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]benzamide;2-(2,4-dichlorophenyl)-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]acetamide;3-phenylmethoxy-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;2-phenyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]acetamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]oxane-4-carboxamide |
|---|---|
| PubChem CID | 157049630 |
| Molecular Formula | C136H103Cl2F18N33O10 |
| Molecular Weight | 2772.41 g/mol |
| Exact Mass | 2769.77 |
| IUPAC Name | N-(2-bicyclo[2.2.2]oct-5-enylmethyl)-4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]benzamide;2-(2,4-dichlorophenyl)-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]acetamide;3-phenylmethoxy-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]benzamide;2-phenyl-N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]acetamide;N-[6-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3-yl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide;N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]-2-pyridinyl]oxane-4-carboxamide |
| SMILES | O=C(Cc1ccc(Cl)cc1Cl)Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1.O=C(Cc1ccccc1)Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1.O=C(NCC1CC2C=CC1CC2)c1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cc1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)cn1)C1CCOCC1.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1ccc2c(c1)OCCO2.O=C(Nc1ccc(-n2nc(-c3cccnc3)cc2C(F)(F)F)nn1)c1cccc(OCc2ccccc2)c1 |
| InChI | InChI=1S/C27H19F3N6O2.C25H23F3N4O.C22H15F3N6O3.C21H13Cl2F3N6O.C21H15F3N6O.C20H18F3N5O2/c28-27(29,30)23-15-22(20-9-5-13-31-16-20)35-36(23)25-12-11-24(33-34-25)32-26(37)19-8-4-10-21(14-19)38-17-18-6-2-1-3-7-18;26-25(27,28)23-13-22(19-2-1-11-29-14-19)31-32(23)21-9-7-18(8-10-21)24(33)30-15-20-12-16-3-5-17(20)6-4-16;23-22(24,25)18-11-15(14-2-1-7-26-12-14)30-31(18)20-6-5-19(28-29-20)27-21(32)13-3-4-16-17(10-13)34-9-8-33-16;22-14-4-3-12(15(23)9-14)8-20(33)28-18-5-6-19(30-29-18)32-17(21(24,25)26)10-16(31-32)13-2-1-7-27-11-13;22-21(23,24)17-12-16(15-7-4-10-25-13-15)29-30(17)19-9-8-18(27-28-19)26-20(31)11-14-5-2-1-3-6-14;21-20(22,23)17-10-16(14-2-1-7-24-11-14)27-28(17)15-3-4-18(25-12-15)26-19(29)13-5-8-30-9-6-13/h1-16H,17H2,(H,32,33,37);1-3,5,7-11,13-14,16-17,20H,4,6,12,15H2,(H,30,33);1-7,10-12H,8-9H2,(H,27,28,32);1-7,9-11H,8H2,(H,28,29,33);1-10,12-13H,11H2,(H,26,27,31);1-4,7,10-13H,5-6,8-9H2,(H,25,26,29) |
| InChIKey | AAAVDCKRFSLSBI-UHFFFAOYSA-N |
| XLogP | 27.49 |
| TPSA | 511.79 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 199 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2772.41 |
| LogP ≤ 5 | 27.49 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 37 |
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|